Update on current pharmacologic therapies for diabetic retinopathy.

Sofía M MunsVictor M VillegasHarry W FlynnStephen G Schwartz

Published in: Expert opinion on pharmacotherapy (2023)

Emerging anti-VEGF modalities, integrin antagonists, and anti-inflammatory agents have the potential to improve outcomes with reduced treatment burdens.

Keyphrases

diabetic retinopathy
anti inflammatory
optical coherence tomography
endothelial cells
vascular endothelial growth factor
type diabetes
metabolic syndrome
adipose tissue
insulin resistance
human health
cell adhesion
smoking cessation